| Dr Sherrie Anthony Nunn, OD | |
|
511 Crossing Dr, Suite 102, Lafayette, CO 80026-2628 | |
| (303) 665-2068 | |
| (303) 665-5473 |
| Full Name | Dr Sherrie Anthony Nunn |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 37 Years |
| Location | 511 Crossing Dr, Lafayette, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922007616 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1367 (Colorado) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lafayette Eye Associates, P.c. | 2163313834 | 2 |
News Archive
Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism, a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In a study to be presented Thursday, Jan. 26, in the oral plenary session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with Baylor College of Medicine, Houston, Texas and University of California, San Diego, La Jolla, California, will present their findings on a study titled, Maternal Diet Structures the Breast Milk Microbiome in Association with Human Milk Oligosaccharides and Gut-Associated Bacteria.
› Verified 9 days ago
| Provider Name | Lafayette Eye Associates, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1548432446 PECOS PAC ID: 2163313834 Enrollment ID: O20040323000071 |
News Archive
Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism, a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In a study to be presented Thursday, Jan. 26, in the oral plenary session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with Baylor College of Medicine, Houston, Texas and University of California, San Diego, La Jolla, California, will present their findings on a study titled, Maternal Diet Structures the Breast Milk Microbiome in Association with Human Milk Oligosaccharides and Gut-Associated Bacteria.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sherrie Anthony Nunn, OD 511 Crossing Dr, Suite 202, Lafayette, CO 80026-2628 Ph: (303) 665-2068 | Dr Sherrie Anthony Nunn, OD 511 Crossing Dr, Suite 102, Lafayette, CO 80026-2628 Ph: (303) 665-2068 |
News Archive
Immunomedics announced that it has received notices that the U.S. and Australian patent offices have allowed claims in respective patent applications covering methods for treating a wide range of autoimmune diseases using monoclonal antibodies that bind to the CD22 antigen present on B-lymphocytes.
The latest advances in the treatment of bleeding and clotting disorders will be presented today at the 52nd Annual Meeting of the American Society of Hematology, focusing on venous thrombeombolism, a potentially life-threatening disorder in which abnormal blood clots form in the veins and restrict the flow of blood. New studies examine risk-prediction models and cutting-edge treatment options for patients with VTE.
Bristol-Myers Squibb Company and Pharmasset announced today that the companies have entered into a clinical collaboration agreement to evaluate the utility of BMS-790052, Bristol-Myers Squibb's NS5A replication complex inhibitor, in combination with PSI-7977, Pharmasset's nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus.
In a study to be presented Thursday, Jan. 26, in the oral plenary session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with Baylor College of Medicine, Houston, Texas and University of California, San Diego, La Jolla, California, will present their findings on a study titled, Maternal Diet Structures the Breast Milk Microbiome in Association with Human Milk Oligosaccharides and Gut-Associated Bacteria.
› Verified 9 days ago
Dr. Jennie Cho, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 2677 Trailridge Dr W, Lafayette, CO 80026 Phone: 303-817-8912 | |
Dr. James E Jackson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1120 W South Boulder Road, Suite 102, Lafayette, CO 80026 Phone: 303-665-7577 Fax: 303-665-3633 | |
Keith P Bowen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Dr. Joel Anthony Winter, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 | |
Mountain Top Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1455 Coal Creek Dr Ste J, Lafayette, CO 80026 Phone: 202-746-3321 | |
Lafayette Eye Associates, P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 511 Crossing Dr, Suite 202, Lafayette, CO 80026 Phone: 303-665-5441 Fax: 303-665-5473 | |
Dr. Donna M Ellinger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 280 Exempla Cir, Lafayette, CO 80026 Phone: 303-338-4545 |